Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 5 minute read General business news FalconEye Ventures acquires Scottsdale Quarter in $100m redevelopment push FalconEye Ventures has acquired Scottsdale Quarter and announced a $100M capital campaign to elevate the luxury retail and office destination. Read the full outlook. byPallavi MadhirajuJuly 1, 2025